BTS

SUNDAY, SEPTEMBER 01, 2013
BTS

Free warrants (BTS-W3) The BTS Group's board of directors has approved the offer of free warrants to existing shareholders. The issuance of warrants will provide BTS the flexibility to manage its financial position and accumulate reserves for future inv

 
Since the warrants are still a long way 
from being in the money, there is no 
immediate dilution effect. Thus, we 
maintain our forecasts. We reiterate 
our Outperform call and SOP-based 
target price of THB10.5. Key drivers 
are BTS bagging four extension line 
contracts and more revenue 
contribution from VGI and the 
property business.
What Happened
Apart from the recent interim 
dividend of THB0.19/share (XD on 
22 Aug, payment on 6 Sep), BTS will 
grant 3,972m warrants to existing 
shareholders at no cost. The issuance 
must be approved by the EGM on 11 
Oct 13. The stock will go XW on 16
Oct 13. The allocation ratio is 1 unit of 
warrant (BTS-W3) for every three
existing BTS shares. The term is five
years and the warrants can be 
exercised after three years at a ratio of 
1w:1 common share at THB12.0.
However, BTS-W3 will be listed on 
the SET on 5 Nov 13. 
What We Think
According to the mass transit network 
expansion plan, there are many 
routes to be operated in the next few 
years until 2029, a total of 508 
kilometres. Out of the several lines, 
BTS is now interested in bidding for 
four future lines (total length 78.8km).
Total investment is estimated to be 
THB117bn (civil works c.THB57bn 
and E&M c.THB60bn). Therefore, the 
warrants are aimed at raising funds 
and proceeds are expected to total a 
maximum of THB47.7bn, which adds 
to the funds raised by BTS early this 
year from the sale of its net future 
fare box revenues to BTSGIF.
. BTSGIF 
will pay THB0.117/share as its first 
dividend (XD on 29 Aug).
What You Should Do
BTS’s share price has dropped a 
significant 12% in a month, less than 
the decline in the SET index at 14%. 
However, BTS has given the 
assurance that it will pay a total 
THB21bn in dividends during 
FY14-16. Our target price offers 
potential upside of 42%.